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A B S T R A C T
The present study reports the anti-allergic activity of ethanolic extract of Zizyphus jujuba Mill., 
Rhamnaceae, and its possible mode of action. The effect of extract of Z. jujuba at different 
doses (250, 500 and 1000 mg/kg, orally) was simulated on studied animal models of  asthma 
and allergy:  a) milk induced eosinophilia and leukocytosis; b) compound 48/80 induced mast 
cell degranulation; and, c) active and passive cutaneous anaphylaxis. In addition, extract of 
Z. jujuba’s effect on sensitized guinea pig ileum (ex vivo) and tracheal chain preparations (in-
vitro) were investigated. Treatment with extract of Z. jujuba at all doses significantly: prevented 
the milk-induced eosinophilia and compound 48/80 induced degranulation of mesenteric 
mast cells; decreased passive cutaneous and active anaphylactic reactions. In addition, 
extract of Z. jujuba inhibited acetylcholine as well as histamine induced tracheal chain 
contraction, and also antigen induced contraction of sensitized guinea pig ileum (Shultz-
Dale inhibition test). Furthermore, it  exhibited also free radicals scavenging activity (in vitro). 
The observed anti-allergic and anti-anaphylactic activity of extract of Z. jujuba may be largely 
through the stabilization of mast cells by the membrane presence of phytoconstituents 
(steroidal saponins and flavonoids).
© 2013 Elsevier Editora Ltda. 
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Introduction
The allergy is an immune disease origin  which includes 
asthma, rhinitis, atopic eczema and dermatitis syndrome 
(Xie and He, 2005). Anaphylaxis is a hyper response to 
antigen cross-linking of IgE bound to mast cells, its causes 
degranulation leading to the release of mediators such as 
histamine,  prostaglandins and later on, proteases, leukotrienes 
and several pro-inﬂammatory and chemotactic cytokines 
(Kalesnikoff and Galli, 2008) triggering smooth muscle 
contraction, vasodilatation, increased vascular permeability 
and mucous hyper secretion (Cavalher-Machado et al., 2008).
Zizyphus jujuba Mill, called as Red date, Chinese date, and 
Bera (Pushto) belongs to family Rhamnaceae which constitute 
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fifty genera and more than 900 species. The Z. jujuba fruit has 
been described to the ‘‘fruit of life” and used in traditional 
Chinese medicine. In addition, it is also used in the treatment 
of various physiological functions of the body viz. digestive 
disorders, weakness, urinary tract infections, diabetes, skin 
infections, loss of appetite, fever, pharyngitis, bronchitis, 
anemia, hyperlipidemia, and diarrhea (Bown, 1995; Him-
Che, 1985). The fresh leaves of Z. mauritiana L (one of the 
species) are used in jaundice (Gul et al., 2009), and it contains 
therapeutically active phytochemicals, vitamin C, phenolic 
compounds, flavonoids, triterpenic acids, and polysaccharides. 
Documented reports of jujuba fruits also shown to produce 
anti-inflammatory, anti-obesity, immune-stimulating, 
antioxidant, gastrointestinal and hepatoprotective effect and 
inhibit foam cell formation in macrophages (Gao et al., 2013) 
and jujuba containing herbal formulation found to exhibit 
anticancer activity (Saif et al., 2010).
Z. jujuba grows in Ahamadnagar, Maharashtra State and 
commonly called the Indian date and fruits of this plant are 
edible and used for the treatment of various diseases such 
as pharyngitis, bronchitis, inflammation, liver diseases, and 
skin infections by local tribal people. Although, Z. jujuba is 
traditionally used for allergy disorder, there is no scientific 
data available on allergy related disorders. Therefore, objective 
of the study was evaluation of anti-allergic and anaphylactic 
activity of ethanolic extract of Zizyphus jujuba fruit in animals 
models and in-vitro condition and also to understand its mode 
of action.
Materials and methods
Animals 
Wistar rats (150-200 g), Swiss albino mice (20-25 g), Dunkin-
Hartley guinea pigs (350-400 g) of either sex were purchased 
from Indian Toxicological Institute, Pune. Animals were 
maintained in our animal house under conditions [temperature 
(24 ± 1°C), relative humidity (45-55%), light (12 h) and dark 
(12 h) cycle] and free access to ready-made food pellets and 
water ad libitum. The experimental protocols were approved 
by the Institutional Animal Ethics Committee (SCOP/IAEC/
Approval/2008-09/13).
Drugs, chemicals and reagents
Compound 48/80 (Sigma Aldrich,  USA),  histamine 
hydrochloride (Analab Fine Chemicals, Mumbai), egg albumin 
(Loba Chemie, Mumbai), horse serum (Serum Institute of 
India Ltd., Pune) and other drugs, dexamethasone, ketotifen 
fumerate (Cipla Healthcare Ltd., India) were procured.
Preparation of ethanolic extract of Z. jujuba fruits (EEZJ)
The fruits of Zizyphus jujuba Mill, Rhamnaceae, were collected 
in the month of December from local supplier, Pune. The plant 
materials was authenticated in the Botany Department of 
Agharkar Research Institute, Pune, Maharashtra India (voucher 
specimen number, Auth. 09-02) and deposited. The fruits were 
shade dried, powdered and sieved through 40# mesh. The dried 
powder (1000 g) of fruits was extracted by cold maceration for 
72 h with ethanol (95%). The ethanolic extract was filtered and 
concentrated in rotary vacuum evaporator to yield semi solid 
extract (yield-7.13% w/w) and preserved at 10°C.
Phytochemical analysis of EEZJ
The phytochemical analysis of EEZJ for the presence of 
alkaloid, saponins, flavonoids, tannins and proteins and 
spectral studies, FT-IR and UV were performed.
Thin layer chromatography of EEZJ
TLC was performed on pre-coated plates of silica gel 60 F254 
(Merck) using solvent system (benzene:ethyl acetate:formic 
acid, 36:12:5).  The phytoconstituents separated on 
chromatographic plate by running reference compounds 
(Betulinic acid, oleanolic acid, betulin and lupeol) were 
identified by spraying the mixture of anisaldehyde and sulfuric 
acid and scanned at 314 nm and spotted.
Drug preparation
Dexamethasone, ketotifen fumerate, ibuprofen and EEZJ were 
freshly prepared as 1% w/v suspension uniform incarboxy 
methyl cellulose (CMC) prior to administration.
Acute toxicity study 
Acute toxicity of EEZJ was performed by oral route in mice as 
per OECD guidelines 423. 
Anti-allergic activity evaluation
Effect of EEZJ on milk-induced leukocytosis and eosinophilia 
in mice 
Swiss albino mice (20-25 g) were randomly divided into 
five groups (6/group). Group-I received CMC (10 ml/kg, p.o.), 
administered group II boiled and cooled milk [4 ml/kg, 
subcutaneously (s.c.)] and groups, III, IV, V and VI received EEZJ 
(250, 500 and 1000 mg/kg, p.o.) and dexamethasone (0.27 mg/
kg, i.p.) respectively. One hour later, all groups of mice received 
boiled and cooled milk (4 ml/kg, s.c.). Blood samples were 
collected before and 24 h after  milk administration from retro-
orbital plexus, under light ether anesthesia and full eosinophils 
and leukocytes were counted (Bhargava and Singh, 1981).
Passive cutaneous anaphylaxis in rats 
Rats were sensitized with 100 μg of egg albumin (EA) adsorbed 
on 12 mg of aluminum hydroxide (adjuvant) s.c. on 1st, 3rd and 
5th day. On 11th day, the blood samples were collected and 
serum was separated. The rats were randomly divided into 
five groups (6/group). The rat homologous antiserum (100 μl) 
was injected s.c. into the shaved dorsal skin of rats. After 24 
h, group I (induced control) received CMC suspension (1% w/v 
10 ml/kg, p.o.), group II, III, and IV received EEZJ (250, 500 and 
1000 mg/kg, p.o., respectively) and group V dexamethasone 
(0.27 mg/kg, i.p.). The rats of all groups were injected 
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intravenously with 0.5 ml of solution containing mixture 
(1:1) of Evan’s blue (0.5% w/v) and EA (100 μg) via tail vein, 30 
min after the drug/extract treatment. Area of leakage of the 
blue dye was measured with the help of Vernier Caliper and 
expressed as mm2 (Gautam et al., 1989).
Effect of EEZJ on serum IgE in rats
The sensitized rats by the procedure described earlier were 
randomly divided into four groups (6/group): Group I (induced 
control) received orally CMC; group II and III, received 
EEZJ 500 and 1000 mg/kg, orally respectively and group IV 
dexamethasone (0.27 mg/kg, i.p.) from 4th day onwards up to 
10th day. The blood samples of sensitized rats were collected 
on 6th , 8th  and 11th  day and serum IgE was assayed.
Serum IgE was determined by sandwich ELISA using 
anti-rat IgE antibody to capture reagent, and biotin-
conjugated anti-rat IgE antibody as detection reagent. 
Thereafter, peroxidase conjugated extravidin and OPD-H2O2 
were added. IgE standard used in the concentration range 
of 0.15- 20 ng/ml and samples were diluted to between 1/20 
and 1/200. The relative concentration of anti-egg albumin 
IgE was calculated by comparing with the pooled serum 
sample of diluted egg albumin-immunized rats to which 
10 AU/ml were assigned.
Active anaphylaxis in rats 
Thirty rats were sensitized by injecting (s.c.) 0.5 ml of horse 
serum/rat. Sensitized rats were randomly divided into five 
groups (6/group). Group II served the induced control received 
CMC (10 ml/kg, p.o.). Groups III, IV and V were administered 
EEZJ (250, 500 and 1000 mg/kg, p.o.) respectively, and group 
VI with dexamethasone (0.27 mg/kg, i.p.) daily for ten days. 
Group I did not receive any treatment and served the usual 
control. On 10th day, 2 h after the treatment, the rats were 
challenged with 0.25 ml (diluted 1:1 in standard saline) 
horse serum/rat by intravenous injection. The symptoms of 
anaphylactic reactions like respiratory distress, increased 
respiratory rate, dyspnoea, cyanosis and mortality were 
recorded. The severities of anaphylactic reactions were 
respiratory scored on a scale (0-20). The scoring system was: 
increased respiratory rate (2), dyspnea for 10 min. (4), dyspnea 
and cyanosis for 10 min (8) and respiratory collapse and death 
(12) (Mitra et al., 1999).
Histamine induced paw edema 
Rats were divided into five groups (6/group) and treated with 
EEZJ (500 and 1000 mg/kg, p.o.) and ibuprofen (50 mg/kg, 
p.o.) and vehicle control (CMC, p.o.). Normal control group 
did not receive any treatment. The EEZJ and ibuprofen 
were administered 30 min prior to the injection of 0.1 ml 
histamine (1% w/v) into the planter region of the right paw 
of each rat (Holsapple et al., 1980). The paw volume was 
measured prior, at 2 and 3 h using plethysmometer (Orchid 
scientifics, Nashik).
Effect of EEZJ on compound 48/80 induced mast cell 
degranulation in rats
Thirty rats were sensitized with compound 48/80 (1 mg/
kg, s.c.).The sensitized rats were randomly divided into five 
groups (6/group). Group II induced control, and received 
(CMC, p.o.). Group II, III, IV received EEZJ (250, 500 and 1000 
mg/kg, p.o., respectively) and group V ketotifen fumerate (1 
mg/kg, i.p.), daily for seven days. Group I normal untreated 
control. On the 7th day, rats were injected (i.p.) 10 ml cold 
phosphate buffered saline. After a gentle abdominal 
massage, animals were sacrificed; the peritoneal fluid 
was collected and transferred into siliconized test tube 
containing 7-10 ml of phosphate buffer (pH 7.4). Mast 
cell viability was checked by Trypan blue dye (0.4%) 
exclusion test. Mast cells were purified by percoll density 
centrifugation method. The pellets of mast cells were 
resuspended in phosphate buffer solution and incubated 
with compound 48/80 (5 μg/ml) at 37°C for 10 min. After 
incubation, cells were centrifuged and stained with 
Toluidine blue (0.1%). Degranulated and intact mast cells 
were counted under high power microscopy and percent 
degranulation was calculated (Andhare et al., 2012).
Effect of EEZJ on histamine induced contraction of isolated 
guinea pig ileum preparation
Fasted guinea pigswere sacrificed and ileum was isolated 
and mounted in an organ bath containing Tyrode solution, 
aerated at 37 ± 0.5°C and dose response curves of histamine 
was studied in the presence and absence of EEZJ and 
chlorpheniramine maleate and IC50 was calculated.
Shultz-Dale inhibition test
Male guinea pigs were sensitized with EA (10 mg/kg, 
i.p.) on the 1st and 3rd day. On the 14th day, guinea pigs 
were sacrificed and isolated ileal strip from each animal, 
suspended in an organ bath containing aerated Tyrode 
solution at 37°C. Tissue sensitivity was tested with 
histamine (0.05 μg/ml). EA (10 μg/ml) was added and 
responses were recorded for 90 s on a Sherrington’s rotating 
drum. Various concentration of EEZJ (10-150 μg/ml) and 
disodium cromoglycate (5-10 μg/ml) were added to bath 
prior to EA and contraction of ileal strips were recorded. 
The control group induced ileum contraction with EA 
(10 μg/ml) was 100% considered and compared with 
contraction of ileum with the test groups (sensitized and 
treated with EEZJ and disodium cromoglyacate). The percent 
inhibition of ileum contraction was calculated.
Effect of EEZJ on guinea pig tracheal chain preparation
Guinea pig trachea was cut into individual rings and tied 
together in series to form a chain. Tracheal chain was 
suspended in Kreb’s solution, aerated at 37°C and response 
curve of acetylcholine (Ach) was studied in the presence 
and absence of atropine and EEZJ  maleate and IC50 was 
calculated (Chaudhari and Lahiri, 1974).
Statistical analysis
The mean ± SEM values were calculated for each group. 
Analysis of variance (ANOVA) followed by Tukey-Kramer 
multiple comparisons test was used for statistical analysis. 
Values of p < 0.05 were considered statistically significance.
IC50 values were calculated by the method of Litchfield and 
Wilcoxon.
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Chart 1 
Preliminary physicochemical studies of ethanolic extract 
of Ziziphus jujuba fruits.
Results
Preliminary phytochemical analysis 
The preliminary phytochemical analyses of EEZJ showed the 
presence of saponins, alkaloids, carbohydrates, proteins, and 
flavonoids and are outlinedin Chart 1.
Thin layer chromatography of EEZJ
The TLC profile clearly indicates the presence of four 
phytoconstituents (betulinic acid, oleanolic acid, betulin and 
lupeol) identified on the basis of color density: oleanolic acid 
(Rf 0.56) dark violet, betulinic acid (Rf 0.57) light violet, botulin 
(Rf 0.48) violet and lupeol (Rf 0.72) darker violet (Fig. 1A and 1B).
Acute toxicity study
EEZJ treatment up to 2000 mg/kg orally to mice did not induce 
mortality or clinical during 96 h observation period. Hence, 
LD50 was considered to be more than 2000 mg/kg. Based on 
acute toxicity results, 250, 500 and 1000 mg/kg doses were 
selected for EEZJ of anti-allergy and anti-anaphylaxis studies.
Anti-allergic activity screening
Effect of EEZJ on milk induced eosinophilia, leukocytosis, and 
differential leukocytes count 
Subcutaneous administration of full milk significantly elevated 
eosinophils, WBC’s and differential leukocytes (neutrophils 
and monocytes) in rats. Pretreatment with EEZJ (500 mg/kg 
and 1000 mg/kg, p.o), dose dependently reduced milk induced 
eosinophilia, leukocytosis, monocytes, and neutrophils. 
Dexamethasone treatment showed a greater reduction of blood 
cells (Table 1).
Test Observation
Nature and 
appearance
Semi solid, reddish Brown 
Solubility Soluble (water, ethanol, methanol), insoluble 
(toluene, acetone, benzene)
UV (EtOH) λ max 257, 314
IR spectra νmax 
at KBr
EZJ IR values: IR cm~ 3366 (–OH Stretch), 2927 
(-CH stretch), 1733 (-C=O)
Phytochemicals 
present
Saponins (++), Alkaloids (++), Proteins (++), 
flavonoids (++), Triterpenoids  (++),  
Tannins (++)
  (++) moderate; (+) mild.
Fig. 1 – A, TLC profile of ethanolic extract of Ziziphus jujuba fruits. B, Rf value of phyto-constituents.
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Table 1 
Effect of ethanolic extract of Ziziphus jujuba fruits on milk induced eosinophilia, leukocytosis and differential leukocytes in 
mice.
Table 2 
Effect of ethanolic extract of Ziziphus jujuba fruits on anaphylaxis (passive  and active cutaneous) and compound 48/80 
induced mast cell degranulation (in vivo).
Effect of EEZJ on anaphylaxis (passive  and active cutaneous) 
and compound 48/80 induced mast cell degranulation (in vivo)
Pretreatment with EEZJ the reduced  dose dependently passive 
cutaneous reaction  Pretreatment of sensitized rats with EEZJ 
and dexamethasone ameliorated anaphylactic reactions 
(decreased the respiratory score) determined by considering 
respiratory rate, dyspnea, cyanosis, and mortality due to 
challenge. Rats sensitized with compound 48/80 (1 mg/kg, s.c.), 
and subsequently treated with EEZJ produced dose dependent 
protection against mast cell degranulation due to the following 
challenge. Reference drug (ketotifen fumerate, 1 mg/kg, p.o.) 
treatment produced a greater protection against mast cell 
granulation than EEZJ (Table 2). 
 Effect of EEZJ on histamine and Ach induced contraction 
response of isolated guinea pig ileum and tracheal chain 
preparations respectively
Histamine elicited a dose dependent contraction in guinea pig 
ileum preparation and its responses were significantly inhibited 
in the presence of EEZJ and chlorpheniramine maleate. The 
IC50 values of histamine responses is chlorpheniramine 
maleate [0.24 (0.22-0.26) μg/ml] and EEZJ [425 (350-510) μg/
ml] were calculated. Acetylcholine produced dose dependent 
contraction in guinea pig tracheal chain preparation and its 
responses were  dose dependently reduced in the presence of 
atropine and EEZJ  maleate. The IC50 values of Ach responses 
for atropine maleate [2.85 (2.6-3.4) ng/ml] and EEZJ [265 (241-
292) μg/ml] were calculated [Table 3].
Treatment
(mg/kg)
Eosinophilisper cu. mm
(×10c/μl)a
Differential Leukocytes
(×10c/μl)b Total Leukocytes  
per cu. mmc
Neutrophils Monocytes
Normal control (NC) 68.88 ± 7.09 3.20 ± 0.40 33.4 ± 1.2 6120 ± 28.0
Induced control (IC) 158.80 ± 13.46 10.60 ± 0.84 48.4 ± 1.0 9920 ± 50.9
EZJ (250, p.o.) 120.20 ± 11.67 6.8 ± 0.8 44.2 ± 1.2 8890 ± 56.4
EZJ (500,  p.o.) 102.00 ± 10.74 7.2 ± 0.6 38.3 ± 1.0 8690 ± 54.2
EZJ (1000,  p.o.) 94. 00 ± 9.90 6.3 ± 0.8 34.3 ± 1.2 8420 ± 26.0
Dexamethasone (0.27, i.p.) 89.40 ± 7.71 6.1 ± 0.7+ 32.8 ± 1.02 7980 ± 24
Treatment
(mg/kg, orally)
Passive cutaneous anaphylaxis Active anaphylaxis Mast cell degranulation
mm3 of blueing 
reaction
Onset of behavioral symptoms 
in min
(% mortality)
Respiratory score
(% mortality)
Intact Degranulated 
(% protection)
Normal control (NC) 0 Normal 0 (0) 100 0
Induced control (IC)
76.35 ± 6.64 Respiratory distress/collapse, 
3-5 min (70)
8.80 ± 7.70(60) 23.20 ± 2.51 76.80 ± 7.77
EZJ (250) 65.50 ± 5.74 Dyspnea, 4-8 min (40) 6.40 ± 4.55(50) 28.40 ± 2.52 71.60 ± 5.67(6.77)
EZJ (500) 59.38 ± 6.60 Dyspnea, 10-15 min (20) 5.20 ± 6.57(30) 35.60 ± 3.22 64.40 ± 6.72(16.14)
EZJ (1000) 54.35 ± 5.46 Normal (0) 2.40 ± 1.30(20) 43.20 ± 3.99 56.80 ± 4.60(26.04)
Dexamethasone (0.27) 46.40 ± 6.50 Normal (0) 2.00 ± 1.23(10) - -
Ketotifen (1) - - - 60.40 ± 4.31 41.60 ± 2.53(45.83)
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Effect of EEZJ on serum IgE in rats
The antibody (IgE) formation was reduced at equally at both 
doses of EEZJ (500/1000 mg/kg) treatment. The effect may be 
due to the sealing effect of EEZJ at 500 mg/kg hence, increase in 
dose may not produce greater effect. The reduction of antibody 
formation by EEZJ (500/1000 mg/kg) was comparable to that of 
dexamethasone (0.27 mg/kg, i.p.) effect (Table 4).
Table 3 
IC50 values of histamine and Ach on isolated guinea pig 
ileum and tracheal chain preparations respectively.
Table 5 
Effect of ethanolic extract of Ziziphus jujuba fruits  on histamine induced hind paw edema in rats and inhibition Shultz-Dale 
reaction  in guinea pig ileum (ex vivo).
Treatment (mg/kg, p.o.) Paw edema (ml) at different time interval
Shultz-Dale reaction in guinea pig ileum  
(% inhibition)
Initial 1 h 3 h - - -
Normal control 0.85 ± 0.04 0.86 ± 0.05 0.86 ± 0.03 -
- -
Induced control 0.87 ± 0.02 1.70 ± 0.08 1.60 ± 0.05 - - -
EZJ (500 mg/kg, p.o.) 0.83 ± 0.01 1.50 ± 0.03 1.42 ± 0.03 - - -
EZJ (1000 mg/kg, p.o.) 0.86 ± 0.03 1.32 ± 0.06 1.30 ± 0.02 - - -
Ibuprofen (50 mg/kg, p.o.) 0.87 ± 0.04 1.30 ± 0.03 1.26 ± 0.04 - - -
EZJ (20/50/100 μg/ml) - - - 34 ± 3.6 54 ± 4.6 74 ± 6.4
Disodium chromoglycate 
(5/10/20 μg/ml)
- - - 51 ± 5.2 62 ± 5.6 76 ± 6.6
Antagonist
IC50 values of
Histamine response 
in the presence of 
antagonist in guinea  
pig ileum
Ach response in the 
presence of antagonist in 
guinea  pig tracheal chain
Nil
16 (14.3-17.9) μg/ml
[100 % contraction]
160 (145-176) μg/ml
[100 % contraction]
Chlorpheniramine 
maleate
0.24 (0.22-0.26) μg/ml
Atropine maleate - 2.85 (2.6-3.4) ng/ml
EZJ 425 (350-510) μg/ml 265 (241-292) μg/ml
Treatment and dose
Serum IgE (μg/ml)
on different days
6 8 11
Albumin sensitized 
control group
4.3 ± 0.12 5.6 ± 0.2 7.8 ± 0.24
EZJ (500 mg/kg, p.o.) 4.0 ± 0.14 3.8 ± 0.1 4.3 ± 0.12
EZJ (1000 mg/kg, p.o.) 4.0 ± 0.11 3.4 ± 0.08 3.9 ± 0.1
Dexamethasone  
(0.27 mg/kg, p.o.)
3.4 ± 0.1 3.0 ± 0.1 3.6 ± 0.1
Table 4
Effect of ethanolic extract of Ziziphus jujuba fruits on serum 
IgE antibodies in rats.
Effect of EEZJ on histamine induced hind paw edema in rats and 
inhibition Shultz-Dale reaction in guinea pig ileum (ex-vivo) 
The injection of histamine into the sub plantar region of 
hind paw of rat induced an edema formation and edema 
was observed peak at 1 h. The rats pretreated with ibuprofen 
and EEZJ significantly inhibited paw edema formation at all 
intervals.
The EA induced contraction response on sensitized guinea 
pig ileum (ex vivo) was dose dependently inhibited d in the 
presence of EEZJ as well as disodium cromoglycate in the 
perfusate (Table 5).
EA 10 mg/ml was taken as 100% contraction and compared 
with drug treated group.
Discussions
Eosinophils are distinguished phenotypically by their bilobed 
nuclei and large acidophilic cytoplasmic granules and 
participating also a major effector cells in allergy, asthma 
and airway function affect. Eosinophil degranulation is an 
important immunological event responsible for allergic 
cutaneous inflammation manifested in cow’s milk. Therefore 
increased  eosinophils reflect the overall  state of allergic 
condition. This is supported by the fact that asthma/allergy 
patients show increased eosinophilia and leukocytosis 
(Horn et al., 1975; Noga et al., 2003) and can serve a sensitive 
cellular biomarker. The overall increased  eosinophils and 
milk leukocytosis following administration may be due to the 
participation of bone marrow and T-cells derived lymphocytes 
(Lenon et al., 2007). During varied type of allergic manifestation, 
variety release inflammatory mediators (histamine, 
leukotrienes C4 and D4, cytokines and basic proteins) which 
provoke edema formation, vascular dilation and eosinophilic 
infiltration (Brigden, 1999; Justice et al., 2003). Prevented EEZJ 
treatment  dose dependently cellular immune reactions,(like 
eosinophilia and leukocytosis) induced by milk in mice may 
have therapeutic implications in type-I hypersensitivity 
reaction and asthma.
 S.R. Naik et al. / Rev Bras Farmacogn 23(2013): 811-818 817
The passive cutaneous anaphylaxis (PCA) and polybasic 
compound 48/80 induced allergic reaction is mediated by 
IgE mainly via increased vascular permeability and release 
of histamine from mast cells. EEZJ treatment prevented 
significantly IgE mediated allergic cutaneous  and 48/80 induced 
systemic allergic reactions associated with inflammation and 
immune responses. Hence, it is believed EEZJ  significant to 
exert anti-allergic activity in type-I IgE-mediated allergic skin 
reaction. Furthermore, prevention of degranulation of mast 
cells may be directly related to EEZJ  formation by blocking 
effect on IgE sensitization phenomena through decreased 
membrane receptor interactions. Our findings are in agreement 
with the report that plant extract rich in flavonoids able to 
prevent IgE responses triggered anaphylactic shock  (Dai 
et al., 2005; Kaneko et al., 2000). It is documented also that 
compound 40/80 increased  permeability of the lipid bilayer 
membrane of membrane perturbation by causing  could and 
trigger the release of mediators from the mast cells (Mousli 
et al., 1990). Such membrane based mechanism might be 
associated with chloride  ion channel or may be responsible 
of elevation of intracellular cAMP  might that provide driving 
force for calcium influx which may activate mast cells (Tasaka 
et al., 1986). Considering such complex cellular events in PCA 
and compound 48/80 IgE mediated type I allergic reactions, 
it is presumed that EEZJ exert inhibitory effect on multiple 
events eventually stabilize lipid membrane as well as G-protein 
activation, through intracellular Ca2+ release process (Han et 
al., 2007).
Experimental findings on isolated guinea pig tracheal chain 
and ileum suggest EEZJ property possesses anti-muscarinic 
and H1 receptor antagonistic property. Further, inhibition 
of histamine induced paw edema indicates significant its 
antihistaminic activity. Hence it is presumed that such 
pharmacological properties of EEZJ may be responsible for 
amelioration of active anaphylactic reactions and improved 
survival rate (Pandit et al., 2008).
The major phytoconstituents of EEZJ are: triterpenoids 
(betulinic acid, betulin, lupeol), steroidal saponins (oleanolic 
acid), flavonoids, xylose and others (not identified), are known 
for antioxidant, cytotoxic, membrane stabilizing property, and 
also exert anti-asthmatic, anti-allergic, anti-complementary, 
immunomodulatory and anti-inflammatory, anti-anaphylactic 
activity and inhibit synthesis of IgE and/or cellular events of 
interaction with mast cell IgE receptors (Fu et al., 2011; Jin et al., 
2011; Kovalenko et al., 2009). Other supporting reports are: coca 
enriched diet (polyphenols, 0.2% w/w) prevents synthesis of IgE 
in OVA induced allergic rat model (Abril-Gil et al., 2012), the 
leaf extract rich in the flavonols myricitrin decreased total IgE 
in an allergy model in transgenic mice (Shimosaki et al., 2011), 
and apple polyphenols are used in the prevention of seasonal 
allergy (Hirano et al., 2009; Wilson et al., 2010).
The  mixture of Adhatoda vasica extract, plant Glycyrrhiza 
glabra, Solanum xanthocarpum, of Albizia lebbeck bark, and roots 
of Picrorhiza kurroa contains flavonoid, triterpenoids, steroidal 
saponins found to stabilize mast cell membrane and exhibit 
anti-asthmatic activity (Iyengar et al., 1994). 
Conclusion 
EEZJ exert potent anti-allergic activity via inhibition of a) IgE 
formation and b) chemical mediators released from mast cells 
by different mechanism(s)  by there support traditional uses of 
Z. jujuba in the treatment of allergy related diseases. EEZJ can 
be developed to an anti-allergic herbal medicine by isolating 
active phytoconstituents individually or in combination and 
conducting clinical trials on human subjects to establish 
themselves its efficacy in the management of allergy and 
anaphylaxis.
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